Second-Generation ALK inhibitors for Therapy of ALK-Rearranged Non-Small Cell Lung Cancer
The majority of lung cancers are non–small cell lung cancers (NSCLCs), which are associated with several gene mutations.
Engineered T Cells for Leukemia: A Review of Current Approaches and Applications
This review addresses the basics of CAR T-cell design and reviews data from published clinical studies in leukemia.
Hypertension Risk Among Cancer Patients Treated With Sunitinib: A Meta-analysis and Systematic Review
Sunitinib treatment is associated with a significantly increased risk of all-grade and high-grade hypertension.
